A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease

Name: A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease
Published: 2016
License: Public Domain

Eisai Co., Ltd. · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

alzheimer-s-disease dementia mild-cognitive-impairment

alzheimer's disease, elenbecestat, e2609, early alzheimer's disease, prodromal alzheimer's disease, dementia, dementia, alzheimer's type, mild cognitive impairment, missionad1, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease

Related documents